Aethlon Medical
AEMD
3 hedge funds and large institutions have $1.88M invested in Aethlon Medical in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 3 → 3 (0)
0% more ownership
Funds ownership: 0% → 0% (+0%)
17% less capital invested
Capital invested by funds: $2.26M → $1.88M (-$383K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$280K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$3K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
AEMD Hedge Fund Activity: Q4 2016 in Review
3 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q4 2016, worth a combined $1.88M — down 17% from $2.26M a quarter earlier.
Fund positioning in AEMD was balanced in Q4 2016: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Vanguard Group, adding an estimated $280K. The largest seller was Royal Bank of Canada, cutting an estimated $3K.
- 3 institutional investors held Aethlon Medical (AEMD) as of Q4 2016, unchanged from Q3 2016.
- Funds reported $1.88M of Aethlon Medical stock for Q4 2016, down 17% quarter-over-quarter.
- 0 funds opened new Aethlon Medical positions in Q4 2016 and 0 closed out.
- The largest Aethlon Medical buyer in Q4 2016 was Vanguard Group, an estimated $280K added.
- The largest Aethlon Medical seller in Q4 2016 was Royal Bank of Canada, an estimated $3K sold.
Based on aggregated 13F filings for Q4 2016.